BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Momeni-Boroujeni A, Chiang S. Uterine mesenchymal tumours: recent advances. Histopathology 2020;76:64-75. [PMID: 31846533 DOI: 10.1111/his.14008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Nakra T, Kakkar A, Mathur SR, Jain D, Kumar S. SMARCA4-deficient Undifferentiated Uterine Sarcoma: Clinicopathological Features of an Emerging Entity. Int J Surg Pathol 2023;31:104-9. [PMID: 35466749 DOI: 10.1177/10668969221095266] [Reference Citation Analysis]
2 Yin X, Wang M, He H, Ru G, Zhao M. Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review. Int J Gynecol Pathol 2023;42:54-62. [PMID: 35081070 DOI: 10.1097/PGP.0000000000000849] [Reference Citation Analysis]
3 Panwar V, Liu Y, Gwin K, Chen H. COL1A1-PDGFB Fusion Associated Fibrosarcoma of the Uterine Corpus: A Case Report and Literature Review. Int J Gynecol Pathol 2022. [PMID: 36729934 DOI: 10.1097/PGP.0000000000000850] [Reference Citation Analysis]
4 Rodriguez Pena MDC, Mubeen A, Harada S, Prieto Granada CN. An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1. Int J Gynecol Pathol 2022. [PMID: 35838627 DOI: 10.1097/PGP.0000000000000894] [Reference Citation Analysis]
5 Dang X, Xiang T, Zhao C, Tang H, Cui P. EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. Front Med (Lausanne) 2022;9:832376. [PMID: 35572973 DOI: 10.3389/fmed.2022.832376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
7 Dundr P, Drozenová J, Matěj R, Bártů M, Němejcová K, Robová H, Rob L, Hojný J, Stružinská I. Desmoplastic Small Round Cell Tumor of the Uterus: A Report of Molecularly Confirmed Case with EWSR1-WT1 Fusion. Diagnostics 2022;12:1184. [DOI: 10.3390/diagnostics12051184] [Reference Citation Analysis]
8 Horn L, Hiller GGR, Mayr D, Schmoeckel E, Höhn AK. Praktisch-diagnostische Aspekte uteriner Leiomyosarkome im Kontext der WHO-Klassifikation 2020. Pathologe 2022;43:196-201. [DOI: 10.1007/s00292-022-01064-6] [Reference Citation Analysis]
9 Bose S, Schwartz GK, Ingham M. Novel Therapeutics in the Treatment of Uterine Sarcoma. Am Soc Clin Oncol Educ Book 2022;42:900-9. [PMID: 35714303 DOI: 10.1200/EDBK_350541] [Reference Citation Analysis]
10 Salvatori R, Manzoni M, Lepanto D, Stufano V, Pessina S, Zanetti C, Bassi F, Mazzarol G, Montagna E, Maffini F. A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements. Tumori. [DOI: 10.1177/03008916221080190] [Reference Citation Analysis]
11 Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku T, Yoshida M, Shikama A, Kogata Y, Terao Y, Tanikawa M, Yasuoka T, Chiyoda T, Miyamoto T, Okadome M, Nakamura T, Enomoto T, Konno Y, Yahata H, Hirata Y, Aoki Y, Tokunaga H, Usui H, Yaegashi N. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group. Hum Pathol 2022:S0046-8177(22)00073-9. [PMID: 35339567 DOI: 10.1016/j.humpath.2022.03.007] [Reference Citation Analysis]
12 Allanson ER, Cummings M, Kuchel A, Wastney T, Nicklin J. Undifferentiated uterine sarcoma: a multidisciplinary challenge. Int J Gynecol Cancer 2022;32:198-202. [DOI: 10.1136/ijgc-2021-003215] [Reference Citation Analysis]
13 Chiang S. Mesenchymal Tumors, Pathology of the Uterine Corpus. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5626-1] [Reference Citation Analysis]
14 Dessources K, Miller KM, Kertowidjojo E, Da Cruz Paula A, Zou Y, Selenica P, da Silva EM, Benayed R, Ashley CW, Abu-rustum NR, Dogan S, Soslow RA, Hensley ML, Weigelt B, Chiang S. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. Mod Pathol. [DOI: 10.1038/s41379-021-01003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Mori S, Gotoh O, Kiyotani K, Low SK. Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms. J Hum Genet 2021;66:853-68. [PMID: 34092788 DOI: 10.1038/s10038-021-00940-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Baa AK, Rastogi S, Tripathy S, Shamim SA, Menon S. Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report. Gynecol Oncol Rep 2021;37:100788. [PMID: 34095424 DOI: 10.1016/j.gore.2021.100788] [Reference Citation Analysis]
18 Wang T, Gong J, Li Q, Chu C, Shen W, Peng W, Gu Y, Li W. A combined radiomics and clinical variables model for prediction of malignancy in T2 hyperintense uterine mesenchymal tumors on MRI. Eur Radiol 2021;31:6125-35. [PMID: 33486606 DOI: 10.1007/s00330-020-07678-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
19 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
20 Soslow RA, Hameed M. Mesenchymal and Mixed Epithelial–Stromal Malignant Tumors of the Cervix. Atlas of Diagnostic Pathology of the Cervix 2021. [DOI: 10.1007/978-3-030-49954-9_11] [Reference Citation Analysis]
21 Chiang S. Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms. Genes Chromosomes Cancer 2021;60:138-46. [PMID: 33230916 DOI: 10.1002/gcc.22920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Chiang S. S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting. Int J Gynecol Pathol 2021;40:24-7. [PMID: 33290352 DOI: 10.1097/PGP.0000000000000702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Croce S, Hostein I, McCluggage WG. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms. Genes Chromosomes Cancer 2021;60:147-59. [PMID: 33099837 DOI: 10.1002/gcc.22910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
24 Davis JL, Rudzinski ER. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know? Curr Treat Options Oncol 2020;21:90. [PMID: 32875423 DOI: 10.1007/s11864-020-00785-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Boyle W, Williams A, Sundar S, Yap J, Taniere P, Rehal P, Ganesan R. TMP3-NTRK1 rearranged uterine sarcoma: A case report. Case Rep Womens Health 2020;28:e00246. [PMID: 32939344 DOI: 10.1016/j.crwh.2020.e00246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rizzo A, Nannini M, Astolfi A, Indio V, De Iaco P, Perrone AM, De Leo A, Incorvaia L, Di Scioscio V, Pantaleo MA. Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis. Cancers (Basel) 2020;12:E1899. [PMID: 32674439 DOI: 10.3390/cancers12071899] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
27 Cotrino I, Carosso A, Macchi C, Baima Poma C, Cosma S, Ribotta M, Viora E, Sciarrone A, Borella F, Zola P. Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs). Eur J Obstet Gynecol Reprod Biol 2020;251:167-72. [PMID: 32505056 DOI: 10.1016/j.ejogrb.2020.05.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Kord A, Eppurath A, Drammeh H, Elbaz Younes I, Xie KL. SMARCA4-deficient uterine sarcoma: A case report and a concise review. Case Rep Womens Health 2020;27:e00231. [PMID: 32551237 DOI: 10.1016/j.crwh.2020.e00231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Patel SB, McCormack C, Hodge JC. Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation? J Clin Pathol 2020;73:830-5. [PMID: 32385140 DOI: 10.1136/jclinpath-2020-206432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ganesan R. Uterine smooth muscle tumour of uncertain malignant potential (STUMP): Where are we now? Case Rep Womens Health 2020;26:e00176. [PMID: 32055453 DOI: 10.1016/j.crwh.2020.e00176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]